We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Minimally Invasive Breast Biopsy Device

By HospiMedica staff writers
Posted on 17 Dec 2004
A new rotational large-core breast biopsy device is a fully automated, disposable handheld device that offers a minimally invasive alternative to traditional breast biopsy devices.

Called Cassi, the device requires no set-up time, performs quickly, and requires no capital equipment investment, saving doctors time and cost. More...
The device uses proprietary Stick Freeze technology to deliver large, precise tissue samples with fewer passes. Once in place, Cassi quickly immobilizes the lesion with a "stick freeze” that secures the targeted tissue to the biopsy needle. A cutting cannula then rotates quickly over the needle to obtain the tissue sample. Larger tissue samples are proving more reliable than fine-needle aspirations in helping doctors to accurately diagnose the nature of a lesion.

Cassi and Stick Freeze were developed by Sanarus Medical, Inc. (Pleasanton, CA, USA). When a breast lump is detected during a visit to a doctor's office, Cassi can be used to perform a biopsy immediately and with local anesthesia. This may eliminate the need to schedule a return visit to perform the biopsy and is less stressful for patients.

"Recently, Cassi proved instrumental in helping me obtain a quality tissue specimen from one of my patients,” explained Dr. Angela Soto Hamlin , a private-practice breast care surgeon in Lemoyne (PA, USA). "From this specimen I was able to make a more accurate diagnosis, one that helped me avoid the delay of scheduling her biopsy for another day or sending her to the operating room.”




Related Links:
Sanarus Medical

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.